[1] Turke AB, Zejnullahu K, Wu YL, et al. Preexistence and clonal selection of MET amplification in EGFR mutant NSCLC. Cancer Cell, 2010; 17, 77−88. doi:  10.1016/j.ccr.2009.11.022
[2] Engelman JA, Zejnullahu K, Mitsudomi T, et al. MET amplification leads to gefitinib resistance in lung cancer by activating ERBB3 signaling. Science, 2007; 316, 1039−43. doi:  10.1126/science.1141478
[3] Jagadeeswaran R, Jagadeeswaran S, Bindokas VP, et al. Activation of HGF/c-Met pathway contributes to the reactive oxygen species generation and motility of small cell lung cancer cells. Am J Physiol Lung Cell Mol Physiol, 2007; 292, L1488−94. doi:  10.1152/ajplung.00147.2006
[4] Shimoda H, Ninomiya K, Nishida N, et al. Anti-hyperlipidemic sesquiterpenes and new sesquiterpene glycosides from the leaves of artichoke (Cynara scolymus L. ): structure requirement and mode of action. Bioorg Med Chem Lett, 2003; 13, 223−8. doi:  10.1016/S0960-894X(02)00889-2
[5] Seo SY, Joo SH, Lee SO, et al. Cynaropicrin induces the apoptosis of colorectal cancer cells by elevating reactive oxygen species and activating the JNK/p38 MAPK. Am J Cancer Res, 2025; 15, 2140−52. doi:  10.62347/OPNG2835
[6] Trott O, Olson AJ. AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J Comput Chem, 2010; 31, 455−61. doi:  10.1002/jcc.21334
[7] Tobwala S, Fan WL, Hines CJ, et al. Antioxidant potential of Sutherlandia frutescens and its protective effects against oxidative stress in various cell cultures. BMC Complement Altern Med, 2014; 14, 271. doi:  10.1186/1472-6882-14-271
[8] Joo SH, Cho YY, Shim JH. Targeting ferroptosis to overcome drug resistance in cancer: molecular mechanisms and therapeutic prospects. Biomol Ther, 2026; 34, 18−29. doi:  10.4062/biomolther.2025.211
[9] Feng L, Zhao KK, Sun LC, et al. SLC7A11 regulated by NRF2 modulates esophageal squamous cell carcinoma radiosensitivity by inhibiting ferroptosis. J Transl Med, 2021; 19, 367. doi:  10.1186/s12967-021-03042-7
[10] Nam AY, Joo SH, Lee NY, et al. 3-O-acetylrubiarbonol B preferentially targets EGFR and MET over rubiarbonol B to inhibit NSCLC cell growth. PLoS One, 2025; 20, e0329706. doi:  10.1371/journal.pone.0329706